Staphylococcus aureus directly activates eosinophils via platelet-activating factor receptor

Journal of Leukocyte Biology

Volumn 92, Issue 2, 2012, Pages 333-341

  Hosoki, Koa ^a   Nakamura, Akiko ^b   Nagao, Mizuho ^a   Hiraguchi, Yukiko ^a   Tanida, Hisashi ^a   Tokuda, Reiko ^a   Wada, Hideo ^b   Nobori, Tsutomu ^b   Suga, Shigeru ^a   Fujisawa, Takao ^a  

^a MIE NATIONAL HOSPITAL   (Japan)

^b MIE UNIVERSITY HOSPITAL   (Japan)

Author keywords

Atopic dermatitis; Colonization; Cytokines; Degranulation; Phagocytosis; Superoxide

Indexed keywords

ALPHA4 INTEGRIN; FIBROBLAST GROWTH FACTOR 1; FIBRONECTIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 5; INTERLEUKIN 9; PLATELET DERIVED GROWTH FACTOR BB; SUPEROXIDE; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; VASCULOTROPIN;

ARTICLE; ATOPIC DERMATITIS; CELL ACTIVATION; CELL ADHESION; CELL CULTURE; CELL FUNCTION; CELL INTERACTION; CELL SECRETION; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPLASM; EOSINOPHIL; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IMMUNOASSAY; INCUBATION TIME; PHAGOCYTOSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STAPHYLOCOCCUS AUREUS; SUPERNATANT;

ADULT; CELLS, CULTURED; DERMATITIS, ATOPIC; EOSINOPHILS; HUMANS; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, G-PROTEIN-COUPLED; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 84864743951     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0112009     Document Type: Article

References (55)

1. Leyden, J. J., Marples, R. R., Kligman, A. M. (1974) Staphylococcus aureus in the lesions of atopic dermatitis. Br. J. Dermatol. 90, 525-530.
2. Ring, J., Abeck, D., Neuber, K. (1992) Atopic eczema: role of microorganisms on the skin surface. Allergy 47, 265-269.
3. Nilsson, E. J., Henning, C. G., Magnusson, J. (1992) Topical corticoste-roids and Staphylococcus aureus in atopic dermatitis. J. Am. Acad. Dermatol. 27, 29-34.
4. Guzik, T. J., Bzowska, M., Kasprowicz, A., Czerniawska-Mysik, G., Wojcik, K., Szmyd, D., Adamek-Guzik, T., Pryjma, J. (2005) Persistent skin colonization with Staphylococcus aureus in atopic dermatitis: relationship to clinical and immunological parameters. Clin. Exp. Allergy 35, 448-455.
5. Reginald, K., Westritschnig, K., Linhart, B., Focke-Tejkl, M., Jahn-Schmid, B., Eckl-Dorna, J., Heratizadeh, A., Stocklinger, A., Balic, N., Spitzauer, S., Niederberger, V., Werfel, T., Thalhamer, J., Weidinger, S., Novak, N., Ollert, M., Hirschl, A. M., Valenta, R. (2011) Staphylococcus aureus fibronectin-binding protein specifically binds IgE from patients with atopic dermatitis and requires antigen presentation for cellular immune responses. J. Allergy Clin. Immunol. 128, 82-91.e8.
6. Bieber, T. (2008) Atopic dermatitis. N. Engl. J. Med. 358, 1483-1494.
7. Leiferman, K. M., Ackerman, S. J., Sampson, H. A., Haugen, H. S., Ve-nencie, P. Y., Gleich, G. J. (1985) Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis.Comparison with onchocerciasis. N. Engl. J. Med. 313, 282-285.
8. Simon, D., Braathen, L. R., Simon, H. U. (2004) Eosinophils and atopic dermatitis. Allergy 59, 561-570.
9. Morishita, Y., Tada, J., Sato, A., Toi, Y., Kanzaki, H., Akiyama, H., Arata, J. (1999) Possible influences of Staphylococcus aureus on atopic dermatitis- the colonizing features and the effects of staphylococcal enterotox-ins. Clin. Exp. Allergy 29, 1110-1117.
10. Wedi, B., Wieczorek, D., Stunkel, T., Breuer, K., Kapp, A. (2002) Staphy-lococcal exotoxins exert proinflammatory effects through inhibition of eosinophil apoptosis, increased surface antigen expression (CD11b, CD45, CD54, and CD69), and enhanced cytokine-activated oxidative burst, thereby triggering allergic inflammatory reactions. J. Allergy Clin. Immunol. 109, 477-484.
11. Benveniste, J., Henson, P. M., Cochrane, C. G. (1972) Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J. Exp. Med. 136, 1356-1377.
12. Hwang, S. B. (1990) Specific receptors of platelet-activating factor, receptor heterogeneity, and signal transduction mechanisms. J. Lipid. Me-diat. 2, 123-158.
13. Simon, H. U., Tsao, P. W., Siminovitch, K. A., Mills, G. B., Blaser, K. (1994) Functional platelet-activating factor receptors are expressed by monocytes and granulocytes but not by resting or activated T and B lymphocytes from normal individuals or patients with asthma. J. Immunol. 153, 364-377.
14. Chao, W., Olson, M. S. (1993) Platelet-activating factor: receptors and signal transduction. Biochem. J. 292, 617-629.
15. Horie, S., Kita, H. (1994) CD11b/CD18 (Mac-1) is required for degran-ulation of human eosinophils induced by human recombinant granulo-cyte-macrophage colony-stimulating factor and platelet-activating factor. J. Immunol. 152, 5457-5467.
16. Wardlaw, A. J., Moqbel, R., Cromwell, O., Kay, A. B. (1986) Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J. Clin. Invest. 78, 1701-1706.
17. Zoratti, E. M., Sedgwick, J. B., Vrtis, R. R., Busse, W. W. (1991) The effect of platelet-activating factor on the generation of superoxide anion in human eosinophils and neutrophils.J. Allergy Clin. Immunol. 88, 749-758.
18. Kimani, G., Tonnesen, M. G., Henson, P. M. (1988) Stimulation of eosinophil adherence to human vascular endothelial cells in vitro by platelet-activating factor. J. Immunol. 140, 3161-3166.
19. Kishimoto, S., Shimadzu, W., Izumi, T., Shimizu, T., Sagara, H., Fukuda, T., Makino, S., Sugiura, T., Waku, K (1997) Comparison of platelet-activating factor receptor mRNA levels in peripheral blood eosinophils from normal subjects and atopic asthmatic patients. Int. Arch. Allergy Immunol. 114 (Suppl. 1), 60-63.
20. Fillon, S., Soulis, K, Rajasekaran, S., Benedict-Hamilton, H., Radin, J. N., Orihuela, C. J., El Kasmi, K C, Murti, G., Kaushal, D., Gaber, M. W., Weber, J. R., Murray, P. J., Tuomanen, E. I. (2006) Platelet-activating factor receptor and innate immunity: uptake of gram-positive bacterial cell wall into host cells and cell-specific pathophysiology. J. Immunol. 177, 6182-6191.
21. Thornton, J. A., Durick-Eder, K, Tuomanen, E. I. (2010) Pneumococcal pathogenesis: "innate invasion" yet organ-specific damage. J. Mol. Med. (Berl.) 88, 103-107.
22. Yousefi, S., Gold, J. A., Andina, N., Lee, J. J., Kelly, A. M., Kozlowski, E., Schmid, I., Straumann, A, Reichenbach, J., Gleich, G. J., Simon, H. U. (2008) Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat. Med. 14, 949-953.
23. Fujisawa, T., Kato, Y., Nagase, H., Atsuta, J., Terada, A, Iguchi, K, Ka-miya, H., Morita, Y., Kitaura, M., Kawasaki, H., Yoshie, O., Hirai, K (2000) Chemokines induce eosinophil degranulation through CCR-3. J. Allergy Clin. Immunol. 106, 507-513.
24. Nagata, M., Sedgwick, J. B., Kita, H., Busse, W. W. (1998) Granulocyte macrophage colony-stimulating factor augments ICAM-1 and VCAM-1 activation of eosinophil function. Am. J. Respir. Cell Mol. Biol. 19, 158-166.
25. Hogan, S. P., Rosenberg, H. F., Moqbel, R, Phipps, S., Foster, P. S., Lacy, P., Kay, A. B., Rothenberg, M. E. (2008) Eosinophils: biological properties and role in health and disease. Clin. Exp. Allergy 38, 709-750.
26. Yamaguchi, Y, Hayashi, Y, Sugama, Y, Miura, Y, Kasahara, T., Kita-mura, S., Torisu, M., Mita, S., Tominaga, A, Takatsu, K, Suda, T. (1988) Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival: IL-5 as an eosinophil chemotac-tic factor. J. Exp. Med. 167, 1737-1742.
27. Valerius, T., Repp, R, Kalden, J. R., Platzer, E. (1990) Effects of IFN on human eosinophils in comparison with other cytokines. A novel class of eosinophil activators with delayed onset of action. J. Immunol. 145, 2950-2958.
28. Cheng, J. F., Ott, N. L., Peterson, E. A., George, T. J., Hukee, M. J., Gleich, G. J., Leiferman, K M. (1997) Dermal eosinophils in atopic dermatitis undergo cytolytic degeneration. J. Allergy Clin. Immunol. 99, 683-692.
29. Adachi, T., Choudhury, B. K, Stafford, S., Sur, S., Alam, R (2000) The differential role of extracellular signal-regulated kinases and p38 mito-gen-activated protein kinase in eosinophil functions. J. Immunol. 165, 2198-2204.
30. Honda, Z., Ishii, S., Shimizu, T. (2002) Platelet-activating factor receptor. J. Biochem. 131, 773-779.
31. Plager, D. A., Henke, S. A, Matsuwaki, Y, Madaan, A, Squillace, D. L., Dierkhising, R A, Kita, H. (2009) Pimecrolimus reduces eosinophil activation associated with calcium mobilization. Int. Arch. Allergy Immunol. 149, 119-126.
32. Di Cesare, A, Di Meglio, P., Nestle, F. O. (2008) A role for Th17 cells in the immunopathogenesis of atopic dermatitis? J. Invest. Dermatol. 128, 2569-2571.
33. Koga, C, Kabashima, K, Shiraishi, N., Kobayashi, M., Tokura, Y (2008) Possible pathogenic role of Th17 cells for atopic dermatitis. J. Invest. Dermatol. 128, 2625-2630.
34. Toda, M., Leung, D. Y, Molet, S., Boguniewicz, M., Taha, R, Christ-odoulopoulos, P., Fukuda, T., Elias, J. A, Hamid, Q. A. (2003) Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions.J. Allergy Clin. Immunol. 111, 875-881.
35. Cheung, P. F., Wong, C. K, Lam, C. W. (2008) Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: implication for Th17 lymphocytes-mediated allergic inflammation. J. Immunol. 180, 5625-5635.
36. Niebuhr, M., Gathmann, M., Scharonow, H., Mamerow, D., Mommert, S., Balaji, H., Werfel, T. (2011) Staphylococcal a-toxin is a strong inducer of interleukin-17 in humans. Infect. Immun. 79, 1615-1622.
37. Cho, S. H., Strickland, I., Boguniewicz, M., Leung, D. Y (2001) Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin. J. Allergy Clin. Immunol. 108, 269-274.
38. Patti, J. M., Allen, B. L., McGavin, M. J., Hook, M. (1994) MSCRAMM-mediated adherence of microorganisms to host tissues. Annu. Rev. Microbiol. 48, 585-617.
39. Weg, V. B., Williams, T. J., Lobb, R R, Nourshargh, S. (1993) A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo. J. Exp. Med. 177, 561-566.
40. Wayner, E. A, Garcia-Pardo, A, Humphries, M. J., McDonald, J. A., Carter, W. G. (1989) Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J. Cell Biol. 109, 1321-1330.
41. Guan, J. L., Hynes, R O. (1990) Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor a 4 /3 1. Cell 60, 53-61.
42. Furue, M., Sugiyama, H., Tsukamoto, K, Ohtake, N., Tamaki, K (1994) Serum soluble IL-2 receptor (sIL-2R) and eosinophil cationic protein (ECP) levels in atopic dermatitis. J. Dermatol. Sci. 7, 89-95.
43. Halmerbauer, G., Frischer, T., Koller, D. Y (1997) Monitoring of disease activity by measurement of inflammatory markers in atopic dermatitis in childhood. Allergy 52, 765-769.
44. Laan, M. P., Koning, H., Baert, M. R, Oranje, A. P., Buurman, W. A, Savelkoul, H. F., Neijens, H.J. (1998) Levels of soluble intercellular adhesion molecule-1, soluble E-selectin, tumor necrosis factor-a, and soluble tumor necrosis factor receptor p55 and p75 in atopic children. Allergy 53, 51-58.
45. Nutan, F. N., Kanwar, A. J., Parsad, D. (2011) The effect of topically applied corticosteroids on interleukin 1.3 levels in patients with atopic dermatitis. J. Eur. Acad. Dermatol. Venereol, Epub ahead of print.
46. Xing, J., Wu, Y, Ni, B. (2011) Th9: a new player in asthma pathogenesis? J. Asthma 48, 115-125.
47. Fujisawa, T., Katsumata, H., Kato, Y (2008) House dust mite extract induces interleukin-9 expression in human eosinophils. Allergol. Int. 57, 141-146.
48. Yanaba, K, Yoshizaki, A, Asano, Y, Kadono, T., Sato, S. (2011) Serum interleukin 9 levels are increased in patients with systemic sclerosis: association with lower frequency and severity of pulmonary fibrosis. J. Rheumatol. 38, 2193-2197.
49. Namkung, J. H., Lee, J. E., Kim, E., Park, G. T., Yang, H. S., Jang, H. Y, Shin, E. S., Cho, E. Y, Yang, J. M. (2011) An association between IL-9 and IL-9 receptor gene polymorphisms and atopic dermatitis in a Korean population. J. Dermatol. Sci. 62, 16-21.
50. Fujisawa, T., Nagao, M., Hiraguchi, Y, Katsumata, H., Nishimori, H., Iguchi, K, Kato, Y, Higashiura, M., Ogawauchi, I., Tamaki, K (2009) Serum measurement of thymus and activation-regulated chemokine/ CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis. Pediatr. Allergy Immunol. 20, 633-641.
51. Giustizieri, M. L., Mascia, F., Frezzolini, A, De Pita, O., Chinni, L. M., Giannetti, A, Girolomoni, G., Pastore, S. (2001) Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J. Allergy Clin. Immunol. 107, 871-877.
52. Liu, Y J. (2007) Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation. J. Allergy Clin. Immunol. 120, 238-244.
53. Kuitert, L. M., Angus, R. M., Barnes, N. C, Barnes, P. J., Bone, M. F., Chung, K F., Fairfax, A. J., Higenbotham, T. W., O'Connor, B. J., Pi-otrowska, B. et al. (1995) Effect of a novel potent platelet-activating factor antagonist, modipafant, in clinical asthma. Am. J. Respir. Crit. Care Med. 151, 1331-1335.
54. Evans, D. J., Barnes, P. J., Cluzel, M., O'Connor, B.J. (1997) Effects of a potent platelet-activating factor antagonist, SR27417A, on allergen-induced asthmatic responses. Am. J. Respir. Crit. Care Med. 156, 11-16.
55. Kiehl, P., Falkenberg, K, Vogelbruch, M., Kapp, A. (2001) Tissue eosin-ophilia in acute and chronic atopic dermatitis: a morphometric approach using quantitative image analysis of immunostaining. Br. J. Dermatol. 145, 720-729.